Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KCNH2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | COL24A1 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | EFCAB2 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | LAIR2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | B3GNTL1 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | EIF3L | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
mRNA | PTGDR2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | RPS12 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | CRH | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | FSHB | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |